IQVIA is a global leader in advanced analytics, technology, and clinical research services. With an extensive background in vaccine and infectious disease research, IQVIA was commissioned by AVA to ...

The New Hampshire Department of Health and Human Services is providing steps Granite Staters can take to protect themselves ...

But there’s another virus out there that can also cause these symptoms: It’s called respiratory syncytial virus (RSV), and ...

"Sadly, a person from the Midlands region has died from complications due to the flu, becoming our first confirmed ...

During the COVID pandemic, many of us received multiple mRNA vaccines. New work by researchers at the VIB-UGent Center for ...

The Food and Drug Administration (FDA) has approved Abrysvo ® (respiratory syncytial virus [RSV] vaccine) for active immunization for the prevention of lower respiratory tract disease (LRTD) caused by ...

Over 1,800 people in Montana had to be hospitalized with either influenza or COVID-19 during the last respiratory illness ...

Abrysvo is the first and only respiratory syncytial virus (RSV) vaccine indicated for adults younger than 50 years.

Health experts say there are plenty of ways to halt the spread of respiratory illnesses as Michigan's weather grows colder.

The FDA expanded the approval of the bivalent RSV prefusion F (RSVpreF) vaccine (Abrysvo) to include the prevention of lower ...

Pfizer's RSV vaccine Abrysvo receives FDA approval for adults 18-59 at high risk, with extended use for pregnant individuals ...

While it’s a win for Pfizer over GSK and its RSV vaccine Arexvy, which is approved for those 50 and older, it’s difficult to ...